[Breaking] Government: "Moderna Vaccine Effectiveness 94.1%... 72% Prevention of Delta Variant After 1st Dose" View original image

On the 22nd, according to the COVID-19 Vaccination Response Promotion Team, the Moderna vaccine showed a 94.1% efficacy rate based on Phase 3 clinical trial results involving 30,420 participants. Additionally, after administering the first dose to 421,073 people in Canada, the vaccine's effectiveness against variants was confirmed as 83% for the Alpha variant, 77% for the Beta and Gamma variants, and 72% for the Delta variant.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing